ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,673.40
      0.28%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cyclacel Pharmaceuticals Inc (CYCC)

      7. Cyclacel Pharmaceuticals Inc (CYCC) News

      CYCC

      Cyclacel Pharmaceuticals (CYCC)

      Cyclacel Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CYCC
      DateTimeSourceHeadlineSymbolCompany
      05/14/20244:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/08/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/02/20244:30PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ RulesNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      04/30/20241:51PMAllPennyStocks.com$8 Million Private Placement Announcement Sends Biotech FlyingNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      04/30/20247:00AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      04/01/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for CancerNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/19/20244:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/19/20247:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/13/20244:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/07/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/06/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax CreditNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      02/20/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor ConferenceNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      01/30/20249:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical OfficerNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      12/18/20239:00AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP DeletionsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      12/12/20234:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Reverse Stock SplitNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      11/30/20239:15AMGlobeNewswire Inc.Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SECNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      11/28/20235:15PMGlobeNewswire Inc.Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-QNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      11/07/20239:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Third Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      08/09/20234:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      08/03/20239:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      06/14/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/11/20235:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/11/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/11/20234:05PMGlobeNewswire Inc.Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/04/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/04/20239:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial ResultsNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      05/03/20239:15AMGlobeNewswire Inc.Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax CreditNASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/13/20236:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/09/20234:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
      03/08/20235:03PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CYCCCyclacel Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:CYCC